{
  "DOI": "10.1007/s10689-011-9437-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-011-9437-y",
  "alternative-id": [
    "9437"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Pasanisi",
      "given": "Patrizia",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Bruno",
      "given": "Eleonora",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Venturelli",
      "given": "Elisabetta",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Manoukian",
      "given": "Siranoush",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Barile",
      "given": "Monica",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Peissel",
      "given": "Bernard",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "De Giacomi",
      "given": "Clelia",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bonanni",
      "given": "Bernardo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berrino",
      "given": "Jacopo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Berrino",
      "given": "Franco",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2011,
        3,
        31
      ]
    ],
    "date-time": "2011-03-31T11:17:18Z",
    "timestamp": 1301570238000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        6,
        9
      ]
    ],
    "date-time": "2019-06-09T15:19:09Z",
    "timestamp": 1560093549000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        17
      ]
    ],
    "date-time": "2024-04-17T17:17:56Z",
    "timestamp": 1713374276360
  },
  "is-referenced-by-count": 26,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2011,
        4,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2011,
          9
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2011,
            4,
            1
          ]
        ],
        "date-time": "2011-04-01T00:00:00Z",
        "timestamp": 1301616000000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9437-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-011-9437-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-011-9437-y",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "521-528",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2011,
        4,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2011,
        4,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2011,
        9
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S1470-2045(10)70095-4",
      "author": "Endogenous Hormones and Breast Cancer Collaborative Group",
      "doi-asserted-by": "crossref",
      "first-page": "530",
      "journal-title": "Lancet Oncol",
      "key": "9437_CR1",
      "unstructured": "Endogenous Hormones and Breast Cancer Collaborative Group (2010) Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 11:530–542",
      "volume": "11",
      "year": "2010"
    },
    {
      "author": "C Campagnoli",
      "key": "9437_CR2",
      "unstructured": "Campagnoli C, Pasanisi P, Peris C, Berrino F (2008) Insulin-like growth factor-I and breast cancer: epidemiological and clinical data. In: Pasqualini JR (ed) Breast cancer: prognosis, treatment and prevention 2nd Edn. Paris: INFORMA-Healthcare. New York, London",
      "volume-title": "Breast cancer: prognosis, treatment and prevention 2nd Edn. Paris: INFORMA-Healthcare",
      "year": "2008"
    },
    {
      "author": "R Dickson",
      "key": "9437_CR3",
      "unstructured": "Dickson R (1996) Biochemical control of breast development. In: Harris JR, Lippman ME, Morrow M, Hellman S (eds) Diseases of the breast. Lippincott-Raven, Philadelphia",
      "volume-title": "Diseases of the breast",
      "year": "1996"
    },
    {
      "DOI": "10.1152/physrev.1996.76.4.1005",
      "author": "CE Stewart",
      "doi-asserted-by": "crossref",
      "first-page": "1005",
      "journal-title": "Physiol Rev",
      "key": "9437_CR4",
      "unstructured": "Stewart CE, Rotwein P (1996) Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 76:1005–1026",
      "volume": "76",
      "year": "1996"
    },
    {
      "DOI": "10.1038/sj.neo.7900229",
      "author": "JS Oh",
      "doi-asserted-by": "crossref",
      "first-page": "204",
      "journal-title": "Neoplasia",
      "key": "9437_CR5",
      "unstructured": "Oh JS, Kucab JE, Bushel PR et al (2002) Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia 4:204–217",
      "volume": "4",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S1096-6374(00)90004-2",
      "author": "RC Baxter",
      "doi-asserted-by": "crossref",
      "first-page": "S10",
      "issue": "(Suppl A)",
      "journal-title": "Growth Horm IGF Res",
      "key": "9437_CR6",
      "unstructured": "Baxter RC, Butt AJ, Schedlich LJ et al (2000) Antiproliferative and pro-apoptotic activities of insulin-like growth factor-binding protein-3. Growth Horm IGF Res 10((Suppl A)):S10–S11",
      "volume": "10",
      "year": "2000"
    },
    {
      "DOI": "10.1507/endocrj.43.Suppl_S43",
      "author": "CA Conover",
      "doi-asserted-by": "crossref",
      "first-page": "S43",
      "issue": "Suppl",
      "journal-title": "Endocr J",
      "key": "9437_CR7",
      "unstructured": "Conover CA (1996) Regulation and physiological role of insulin-like growth factor binding proteins. Endocr J 43(Suppl):S43–S48",
      "volume": "43",
      "year": "1996"
    },
    {
      "DOI": "10.1007/BF00051703",
      "author": "R Kaaks",
      "doi-asserted-by": "crossref",
      "first-page": "605",
      "journal-title": "Cancer Causes Control",
      "key": "9437_CR8",
      "unstructured": "Kaaks R (1996) Nutrition, hormones, and breast cancer: is insulin the missing link? Cancer Causes Control 7:605–625",
      "volume": "7",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/djj376",
      "author": "AH Eliassen",
      "doi-asserted-by": "crossref",
      "first-page": "1406",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR9",
      "unstructured": "Eliassen AH, Missmer SA, Tworoger SS et al (2006) Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 98:1406–1415",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1677/erc.1.01038",
      "author": "R Kaaks",
      "doi-asserted-by": "crossref",
      "first-page": "1071",
      "journal-title": "Endocr Relat Cancer",
      "key": "9437_CR10",
      "unstructured": "Kaaks R, Rinaldi S, Key TJ et al (2005) Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition. Endocr Relat Cancer 12:1071–1082",
      "volume": "12",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/dji132",
      "author": "R Kaaks",
      "doi-asserted-by": "crossref",
      "first-page": "755",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR11",
      "unstructured": "Kaaks R, Berrino F, Key T et al (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755–765",
      "volume": "97",
      "year": "2005"
    },
    {
      "DOI": "10.1093/jnci/94.8.606",
      "author": "T Key",
      "doi-asserted-by": "crossref",
      "first-page": "606",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR12",
      "unstructured": "Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ijc.20403",
      "author": "A Micheli",
      "doi-asserted-by": "crossref",
      "first-page": "312",
      "journal-title": "Int J Cancer",
      "key": "9437_CR13",
      "unstructured": "Micheli A, Muti P, Secreto G et al (2004) Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 112:312–318",
      "volume": "112",
      "year": "2004"
    },
    {
      "DOI": "10.1080/01635580802610115",
      "author": "A Lautenbach",
      "doi-asserted-by": "crossref",
      "first-page": "484",
      "journal-title": "Nutr Cancer",
      "key": "9437_CR14",
      "unstructured": "Lautenbach A, Budde A, Wrann CD et al (2009) Obesity and the associated mediators leptin, estrogen and IGF-I enhance the cell proliferation and early tumorigenesis of breast cancer cells. Nutr Cancer 61:484–491",
      "volume": "61",
      "year": "2009"
    },
    {
      "DOI": "10.1016/j.ejca.2006.07.019",
      "author": "FP Liebens",
      "doi-asserted-by": "crossref",
      "first-page": "238",
      "journal-title": "Eur J Cancer",
      "key": "9437_CR15",
      "unstructured": "Liebens FP, Carly B, Pastijn A et al (2007) Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006. Eur J Cancer 43:238–257",
      "volume": "43",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "doi-asserted-by": "crossref",
      "key": "9437_CR16",
      "unstructured": "The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310–1316"
    },
    {
      "DOI": "10.1093/jnci/94.18.1365",
      "author": "MS Brose",
      "doi-asserted-by": "crossref",
      "first-page": "1365",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR17",
      "unstructured": "Brose MS, Rebbeck TR, Calzone KA et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. J Natl Cancer Inst 94:1365–1372",
      "volume": "94",
      "year": "2002"
    },
    {
      "author": "DF Easton",
      "first-page": "678",
      "journal-title": "Am J Hum Genet",
      "key": "9437_CR18",
      "unstructured": "Easton DF, Bishop DT, Ford D et al (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52:678–701",
      "volume": "52",
      "year": "1993"
    },
    {
      "DOI": "10.1086/301749",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "676",
      "journal-title": "Am J Hum Genet",
      "key": "9437_CR19",
      "unstructured": "Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet 62:676–689",
      "volume": "62",
      "year": "1998"
    },
    {
      "author": "S Narod",
      "first-page": "957",
      "journal-title": "Am J Hum Genet",
      "key": "9437_CR20",
      "unstructured": "Narod S, Ford D, Devilee P et al (1995) Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. Am J Hum Genet 57:957–958",
      "volume": "57",
      "year": "1995"
    },
    {
      "key": "9437_CR21",
      "unstructured": "Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases (2000) Anglian Breast Cancer Study Group. Br J Cancer 83:1301–1308"
    },
    {
      "DOI": "10.1002/gcc.20199",
      "author": "V Bonadona",
      "doi-asserted-by": "crossref",
      "first-page": "404",
      "journal-title": "Genes Chromosomes Cancer",
      "key": "9437_CR22",
      "unstructured": "Bonadona V, Sinilnikova OM, Chopin S et al (2005) Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France. Genes Chromosomes Cancer 43:404–413",
      "volume": "43",
      "year": "2005"
    },
    {
      "author": "JL Hopper",
      "first-page": "741",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9437_CR23",
      "unstructured": "Hopper JL, Southey MC, Dite GS et al (1999) Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study. Cancer Epidemiol Biomarkers Prev 8:741–747",
      "volume": "8",
      "year": "1999"
    },
    {
      "DOI": "10.1186/bcr632",
      "author": "N Loman",
      "doi-asserted-by": "crossref",
      "first-page": "R175",
      "journal-title": "Breast Cancer Res",
      "key": "9437_CR24",
      "unstructured": "Loman N, Bladstrom A, Johannsson O et al (2003) Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 5:R175–R186",
      "volume": "5",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/91.11.943",
      "author": "J Peto",
      "doi-asserted-by": "crossref",
      "first-page": "943",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR25",
      "unstructured": "Peto J, Collins N, Barfoot R et al (1999) Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–949",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1093/jnci/djj465",
      "author": "HA Risch",
      "doi-asserted-by": "crossref",
      "first-page": "1694",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR26",
      "unstructured": "Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–1706",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1016/S0140-6736(98)03300-5",
      "author": "S Thorlacius",
      "doi-asserted-by": "crossref",
      "first-page": "1337",
      "journal-title": "Lancet",
      "key": "9437_CR27",
      "unstructured": "Thorlacius S, Struewing JP, Hartge P et al (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337–1339",
      "volume": "352",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s10549-006-9161-8",
      "author": "A Nkondjock",
      "doi-asserted-by": "crossref",
      "first-page": "285",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9437_CR28",
      "unstructured": "Nkondjock A, Robidoux A, Paredes Y et al (2006) Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 98:285–294",
      "volume": "98",
      "year": "2006"
    },
    {
      "author": "F Berrino",
      "first-page": "63",
      "journal-title": "IARC Sci Publ",
      "key": "9437_CR29",
      "unstructured": "Berrino F, Pasanisi P, Berrino J et al (2002) A European case-only study on familial breast cancer. IARC Sci Publ 156:63–65",
      "volume": "156",
      "year": "2002"
    },
    {
      "author": "P Pasanisi",
      "first-page": "3040S",
      "journal-title": "J Nutr",
      "key": "9437_CR30",
      "unstructured": "Pasanisi P, Berrino J, Fusconi E et al (2005) A European Case-Only Study (COS) on familial breast cancer. J Nutr 135:3040S–3041S",
      "volume": "135",
      "year": "2005"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-09-0024",
      "author": "P Pasanisi",
      "doi-asserted-by": "crossref",
      "first-page": "2107",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9437_CR31",
      "unstructured": "Pasanisi P, Hedelin G, Berrino J et al (2009) Oral contraceptive use and BRCA penetrance: a case-only study. Cancer Epidemiol Biomarkers Prev 18:2107–2113",
      "volume": "18",
      "year": "2009"
    },
    {
      "DOI": "10.1093/ajcn/80.2.447",
      "author": "C Hoppe",
      "doi-asserted-by": "crossref",
      "first-page": "447",
      "journal-title": "Am J Clin Nutr",
      "key": "9437_CR32",
      "unstructured": "Hoppe C, Udam TR, Lauritzen L et al (2004) Animal protein intake, serum insulin-like growth factor I, and growth in healthy 2.5-year-old Danish children. Am J Clin Nutr 80:447–452",
      "volume": "80",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.ejcn.1602086",
      "author": "C Hoppe",
      "doi-asserted-by": "crossref",
      "first-page": "393",
      "journal-title": "Eur J Clin Nutr",
      "key": "9437_CR33",
      "unstructured": "Hoppe C, Molgaard C, Vaag A et al (2005) High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys. Eur J Clin Nutr 59:393–398",
      "volume": "59",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejcn.1602494",
      "author": "T Norat",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "journal-title": "Eur J Clin Nutr",
      "key": "9437_CR34",
      "unstructured": "Norat T, Dossus L, Rinaldi S et al (2007) Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. Eur J Clin Nutr 61:91–98",
      "volume": "61",
      "year": "2007"
    },
    {
      "author": "MD Holmes",
      "first-page": "852",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9437_CR35",
      "unstructured": "Holmes MD, Pollak MN, Willett WC et al (2002) Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 11:852–861",
      "volume": "11",
      "year": "2002"
    },
    {
      "DOI": "10.1055/s-2007-970415",
      "author": "S Maor",
      "doi-asserted-by": "crossref",
      "first-page": "179",
      "journal-title": "Horm Metab Res",
      "key": "9437_CR36",
      "unstructured": "Maor S, Papa MZ, Yarden RI et al (2007) Insulin-like growth factor-I controls BRCA1 gene expression through activation of transcription factor Sp1. Horm Metab Res 39:179–185",
      "volume": "39",
      "year": "2007"
    },
    {
      "DOI": "10.1016/j.canlet.2007.07.019",
      "author": "S Maor",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "journal-title": "Cancer Lett",
      "key": "9437_CR37",
      "unstructured": "Maor S, Yosepovich A, Papa MZ et al (2007) Elevated insulin-like growth factor-I receptor (IGF-IR) levels in primary breast tumors associated with BRCA1 mutation. Cancer Lett 257:236–243",
      "volume": "257",
      "year": "2007"
    },
    {
      "DOI": "10.1677/ERC-06-0075",
      "author": "G Hudelist",
      "doi-asserted-by": "crossref",
      "first-page": "1053",
      "journal-title": "Endocr Relat Cancer",
      "key": "9437_CR38",
      "unstructured": "Hudelist G, Wagner T, Rosner M et al (2007) Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer 14:1053–1062",
      "volume": "14",
      "year": "2007"
    },
    {
      "DOI": "10.1093/jnci/89.3.227",
      "author": "DA Berry",
      "doi-asserted-by": "crossref",
      "first-page": "227",
      "journal-title": "J Natl Cancer Inst",
      "key": "9437_CR39",
      "unstructured": "Berry DA, Parmigiani G, Sanchez J et al (1997) Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89:227–238",
      "volume": "89",
      "year": "1997"
    },
    {
      "DOI": "10.1086/301670",
      "author": "G Parmigiani",
      "doi-asserted-by": "crossref",
      "first-page": "145",
      "journal-title": "Am J Hum Genet",
      "key": "9437_CR40",
      "unstructured": "Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145–158",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1007/BF00053180",
      "author": "R Capocaccia",
      "doi-asserted-by": "crossref",
      "first-page": "23",
      "journal-title": "Cancer Causes Control",
      "key": "9437_CR41",
      "unstructured": "Capocaccia R, Verdecchia A, Micheli A et al (1990) Breast cancer incidence and prevalence estimated from survival and mortality. Cancer Causes Control 1:23–29",
      "volume": "1",
      "year": "1990"
    },
    {
      "DOI": "10.1086/375033",
      "author": "A Antoniou",
      "doi-asserted-by": "crossref",
      "first-page": "1117",
      "journal-title": "Am J Hum Genet",
      "key": "9437_CR42",
      "unstructured": "Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130",
      "volume": "72",
      "year": "2003"
    },
    {
      "author": "J Chang-Claude",
      "first-page": "272",
      "journal-title": "J Cancer Res Clin Oncol",
      "key": "9437_CR43",
      "unstructured": "Chang-Claude J, Becher H, Eby N et al (1997) Modifying effect of reproductive risk factors on the age at onset of breast cancer for German BRCA1 mutation carriers. J Cancer Res Clin Oncol 123:272–279",
      "volume": "123",
      "year": "1997"
    },
    {
      "DOI": "10.1002/ijc.2910640608",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "394",
      "journal-title": "Int J Cancer",
      "key": "9437_CR44",
      "unstructured": "Narod SA, Goldgar D, Cannon-Albright L et al (1995) Risk modifiers in carriers of BRCA1 mutations. Int J Cancer 64:394–398",
      "volume": "64",
      "year": "1995"
    },
    {
      "DOI": "10.1038/sj.onc.1209870",
      "author": "SA Narod",
      "doi-asserted-by": "crossref",
      "first-page": "5832",
      "journal-title": "Oncogene",
      "key": "9437_CR45",
      "unstructured": "Narod SA (2006) Modifiers of risk of hereditary breast cancer. Oncogene 25:5832–5836",
      "volume": "25",
      "year": "2006"
    },
    {
      "DOI": "10.1016/0169-2607(94)90091-4",
      "author": "G Angelis De",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "journal-title": "Comput Methods Programs Biomed",
      "key": "9437_CR46",
      "unstructured": "De Angelis G, De Angelis R, Frova L et al (1994) MIAMOD: a computer package to estimate chronic disease morbidity using mortality and survival data. Comput Methods Programs Biomed 44:99–107",
      "volume": "44",
      "year": "1994"
    },
    {
      "DOI": "10.1002/sim.4780080207",
      "author": "A Verdecchia",
      "doi-asserted-by": "crossref",
      "first-page": "201",
      "journal-title": "Stat Med",
      "key": "9437_CR47",
      "unstructured": "Verdecchia A, Capocaccia R, Egidi V et al (1989) A method for the estimation of chronic disease morbidity and trends from mortality data. Stat Med 8:201–216",
      "volume": "8",
      "year": "1989"
    },
    {
      "DOI": "10.1007/s10689-007-9176-2",
      "author": "H Roudgari",
      "doi-asserted-by": "crossref",
      "first-page": "199",
      "journal-title": "Fam Cancer",
      "key": "9437_CR48",
      "unstructured": "Roudgari H, Miedzybrodzka ZH, Haites NE (2008) Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models. Fam Cancer 7:199–212",
      "volume": "7",
      "year": "2008"
    },
    {
      "DOI": "10.1200/JCO.2006.09.4318",
      "author": "A Decensi",
      "doi-asserted-by": "crossref",
      "first-page": "4201",
      "journal-title": "J Clin Oncol",
      "key": "9437_CR49",
      "unstructured": "Decensi A, Gandini S, Serrano D et al (2007) Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. J Clin Oncol 25:4201–4209",
      "volume": "25",
      "year": "2007"
    },
    {
      "DOI": "10.1038/sj.bjc.6602389",
      "author": "H Jernstrom",
      "doi-asserted-by": "crossref",
      "first-page": "857",
      "journal-title": "Br J Cancer",
      "key": "9437_CR50",
      "unstructured": "Jernstrom H, Sandberg T, Bageman E et al (2005) Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast cancer families. Br J Cancer 92:857–866",
      "volume": "92",
      "year": "2005"
    },
    {
      "DOI": "10.1038/ng0396-309",
      "author": "CM Phelan",
      "doi-asserted-by": "crossref",
      "first-page": "309",
      "journal-title": "Nat Genet",
      "key": "9437_CR51",
      "unstructured": "Phelan CM, Rebbeck TR, Weber BL et al (1996) Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet 12:309–311",
      "volume": "12",
      "year": "1996"
    },
    {
      "DOI": "10.1086/302366",
      "author": "TR Rebbeck",
      "doi-asserted-by": "crossref",
      "first-page": "1371",
      "journal-title": "Am J Hum Genet",
      "key": "9437_CR52",
      "unstructured": "Rebbeck TR, Kantoff PW, Krithivas K et al (1999) Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat. Am J Hum Genet 64:1371–1377",
      "volume": "64",
      "year": "1999"
    },
    {
      "DOI": "10.1097/00008571-200110000-00010",
      "author": "IB Runnebaum",
      "doi-asserted-by": "crossref",
      "first-page": "635",
      "journal-title": "Pharmacogenetics",
      "key": "9437_CR53",
      "unstructured": "Runnebaum IB, Wang-Gohrke S, Vesprini D et al (2001) Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics 11:635–638",
      "volume": "11",
      "year": "2001"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-07-0654",
      "author": "P Pasanisi",
      "doi-asserted-by": "crossref",
      "first-page": "1719",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9437_CR54",
      "unstructured": "Pasanisi P, Venturelli E, Morelli D et al (2008) Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 17:1719–1722",
      "volume": "17",
      "year": "2008"
    },
    {
      "DOI": "10.1046/j.1464-410x.2000.00350.x",
      "author": "R Kurek",
      "doi-asserted-by": "crossref",
      "first-page": "125",
      "journal-title": "BJU Int",
      "key": "9437_CR55",
      "unstructured": "Kurek R, Tunn UW, Eckart O et al (2000) The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer. BJU Int 85:125–129",
      "volume": "85",
      "year": "2000"
    },
    {
      "DOI": "10.1515/JPEM.2000.13.S1.739",
      "author": "J Muller",
      "doi-asserted-by": "crossref",
      "first-page": "739",
      "issue": "Suppl 1",
      "journal-title": "J Pediatr Endocrinol Metab",
      "key": "9437_CR56",
      "unstructured": "Muller J, Juul A, Andersson AM et al (2000) Hormonal changes during GnRH analogue therapy in children with central precocious puberty. J Pediatr Endocrinol Metab 13(Suppl 1):739–1746",
      "volume": "13",
      "year": "2000"
    },
    {
      "DOI": "10.1200/JCO.2005.03.6772",
      "author": "S Chen",
      "doi-asserted-by": "crossref",
      "first-page": "863",
      "journal-title": "J Clin Oncol",
      "key": "9437_CR57",
      "unstructured": "Chen S, Iversen ES, Friebel T et al (2006) Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol 24:863–871",
      "volume": "24",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.suc.2008.04.007",
      "doi-asserted-by": "crossref",
      "key": "9437_CR58",
      "unstructured": "Jatoi I, Anderson WF (2008) Management of women who have a genetic predisposition for breast cancer. Surg Clin North Am 88:845–861"
    },
    {
      "DOI": "10.1038/ncponc0930",
      "author": "DH Roukos",
      "doi-asserted-by": "crossref",
      "first-page": "578",
      "journal-title": "Nat Clin Pract Oncol",
      "key": "9437_CR59",
      "unstructured": "Roukos DH, Briasoulis E (2007) Individualized preventive and therapeutic management of hereditary breast ovarian cancer syndrome. Nat Clin Pract Oncol 4:578–590",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ijc.21536",
      "author": "J Gronwald",
      "doi-asserted-by": "crossref",
      "first-page": "2281",
      "journal-title": "Int J Cancer",
      "key": "9437_CR60",
      "unstructured": "Gronwald J, Tung N, Foulkes WD et al (2006) Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer 118:2281–2284",
      "volume": "118",
      "year": "2006"
    },
    {
      "DOI": "10.1007/s10549-010-0769-3",
      "author": "KW Reding",
      "doi-asserted-by": "crossref",
      "first-page": "491",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9437_CR61",
      "unstructured": "Reding KW, Bernstein JL, Langholz BM et al (2010) Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. Breast Cancer Res Treat 23:491–498",
      "volume": "23",
      "year": "2010"
    },
    {
      "DOI": "10.1007/s10552-004-2593-8",
      "author": "J Kotsopoulos",
      "doi-asserted-by": "crossref",
      "first-page": "125",
      "journal-title": "Cancer Causes Control",
      "key": "9437_CR62",
      "unstructured": "Kotsopoulos J, Narod SA (2005) Towards a dietary prevention of hereditary breast cancer. Cancer Causes Control 16:125–138",
      "volume": "16",
      "year": "2005"
    },
    {
      "DOI": "10.1007/s10549-006-9161-8",
      "author": "A Nkondjock",
      "doi-asserted-by": "crossref",
      "first-page": "2852",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9437_CR63",
      "unstructured": "Nkondjock A, Robidoux A, Paredes Y et al (2006) Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians. Breast Cancer Res Treat 98:2852–2894",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1126/science.1088759",
      "author": "MC King",
      "doi-asserted-by": "crossref",
      "first-page": "643",
      "journal-title": "Science",
      "key": "9437_CR64",
      "unstructured": "King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646",
      "volume": "302",
      "year": "2003"
    },
    {
      "DOI": "10.1196/annals.1386.023",
      "author": "F Berrino",
      "doi-asserted-by": "crossref",
      "first-page": "110",
      "journal-title": "Ann N Y Acad Sci",
      "key": "9437_CR65",
      "unstructured": "Berrino F, Villarini A, De Petris M et al (2006) Adjuvant diet to improve hormonal and metabolic factors affecting breast cancer prognosis. Ann N Y Acad Sci 1089:110–118",
      "volume": "1089",
      "year": "2006"
    },
    {
      "DOI": "10.1093/ajcn/84.6.1456",
      "author": "L Fontana",
      "doi-asserted-by": "crossref",
      "first-page": "1456",
      "journal-title": "Am J Clin Nutr",
      "key": "9437_CR66",
      "unstructured": "Fontana L, Klein S, Holloszy JO (2006) Long-term low-protein, low-calorie diet and endurance exercise modulate metabolic factors associated with cancer risk. Am J Clin Nutr 84:1456–1462",
      "volume": "84",
      "year": "2006"
    },
    {
      "DOI": "10.1158/1055-9965.EPI-08-0531",
      "author": "ML Irwin",
      "doi-asserted-by": "crossref",
      "first-page": "306",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9437_CR67",
      "unstructured": "Irwin ML, Varma K, Alvarez-Reeves M et al (2009) Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev 18:306–313",
      "volume": "18",
      "year": "2009"
    },
    {
      "author": "F Berrino",
      "first-page": "25",
      "journal-title": "Cancer Epidemiol Biomarkers Prev",
      "key": "9437_CR68",
      "unstructured": "Berrino F, Bellati C, Secreto G et al (2001) Reducing bioavailable sex hormones through a comprehensive change in diet: the diet and androgens (DIANA) randomized trial. Cancer Epidemiol Biomarkers Prev 10:25–33",
      "volume": "10",
      "year": "2001"
    },
    {
      "DOI": "10.1002/ijc.20582",
      "author": "F Berrino",
      "doi-asserted-by": "crossref",
      "first-page": "499",
      "journal-title": "Int J Cancer",
      "key": "9437_CR69",
      "unstructured": "Berrino F, Pasanisi P, Bellati C et al (2005) Serum testosterone levels and breast cancer recurrence. Int J Cancer 113:499–502",
      "volume": "113",
      "year": "2005"
    },
    {
      "DOI": "10.1038/sj.ejcn.1601647",
      "author": "R Kaaks",
      "doi-asserted-by": "crossref",
      "first-page": "1079",
      "journal-title": "Eur J Clin Nutr",
      "key": "9437_CR70",
      "unstructured": "Kaaks R, Bellati C, Venturelli E et al (2003) Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: the Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 57:1079–1088",
      "volume": "57",
      "year": "2003"
    },
    {
      "DOI": "10.1002/ijc.21812",
      "author": "P Pasanisi",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "journal-title": "Int J Cancer",
      "key": "9437_CR71",
      "unstructured": "Pasanisi P, Berrino F, De Petris M et al (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 119:236–238",
      "volume": "119",
      "year": "2006"
    }
  ],
  "reference-count": 71,
  "references-count": 71,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-011-9437-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families"
  ],
  "type": "journal-article",
  "volume": "10"
}